Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Arris, SKB to research protease inhibitors

July 5, 1996

ArQule, ICAgen collaborate on ion channel modulators

July 5, 1996

Gilead reports important discovery related to genetic code blocker research

July 5, 1996

Eotaxin receptor cloned: Possible implications for asthma research

July 5, 1996

Anergen, Organon to collaborate on RA treatment

July 5, 1996

ArQule obtains rights to Yale's alpha-ketoamide chemistry technology

July 5, 1996

Mitotix in-licenses p27 technology

July 5, 1996

Tripos' ChemSpace available for licensing soon

June 28, 1996

American Biogenetic Sciences obtains antibody technology from MRC

June 28, 1996

Collaboration for oral insulin formulation development

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...